Tech Company Financing Transactions
Ceptyr Funding Round
On 3/31/2005, Ceptyr landed $460 thousand in financing from Arch Venture Partners.
Transaction Overview
Company Name
Announced On
3/31/2005
Transaction Type
Venture Equity
Amount
$460,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Out of Business
Industry
Biopharmaceutical
Mailing Address
12277 134th Ct. NE 100
Redmond, WA 98052
USA
Redmond, WA 98052
USA
Phone
Website
Email Address
Overview
CEPTYR, Inc., was founded to focus on developing drugs against protein tyrosine phosphatases (PTPs), a largely unexplored domain in pharmaceutical development. We assembled the world's leading experts in this field. Excellent progress has been made in identifying compelling PTP targets, and in novel chemistry for inhibitor drugs.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
James Rathmann
Chief Financial Officer
Gerald McGuire
Browse more venture capital transactions:
Prev: 3/31/2005: CITTIO venture capital transaction
Next: 3/31/2005: Replication Medical venture capital transaction
Share this article
About Our VC Transactions Data
We report on every notable VC transaction. VC investment data records on this site come from publicly available VC deal announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs